Skip to main content

and
  1. No Access

    Article

    Informing MS patients on treatment options: a consensus on the process of consent taking

    In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s em...

    C. Tortorella, C. Solaro, P. Annovazzi, L. Boffa, M. C. Buscarinu in Neurological Sciences (2020)

  2. Article

    Erratum: FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

    Correction to: Cell Death and Disease (2015) 6, e1741; doi:10.1038/cddis.2015.100; published online 7 May 2015 Since the publication of this paper the authors have noted that the affiliation addresses were inc...

    M T Cencioni, S Santini, G Ruocco, G Borsellino, M De Bardi in Cell Death & Disease (2015)

  3. Article

    Open Access

    FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

    Functionally distinct T-helper (Th) subsets orchestrate immune responses. Maintenance of homeostasis through the tight control of inflammatory Th cells is crucial to avoid autoimmune inflammation. Activation-I...

    M T Cencioni, S Santini, G Ruocco, G Borsellino, M De Bardi in Cell Death & Disease (2015)

  4. No Access

    Chapter

    Evoluzione della malattia

    La sclerosi multipla (SM) presenta manifestazioni cliniche estremamente variabili sia nelle caratteristiche di esordio sia nell’evoluzione della malattia (decorso, frequenza di ricadute, velocità di progressio...

    C. Gasperini, S. Ruggieri in Aspetti psicologici nella sclerosi multipla (2013)

  5. No Access

    Article

    Differential diagnosis in multiple sclerosis

    Multiple sclerosis can usually be diagnosed from a patient's history, clinical examination, cerebrospinal fluid (CSF) analysis, and observations from magnetic resonance imaging (MRI). However, sometimes, the ...

    C. Gasperini in Neurological Sciences (2001)

  6. No Access

    Article

    The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement

    Phase III definitive treatment trials of new multiple sclerosis (MS) therapies now routinely incorporate an annual magnetic resonance imaging protocol, with change in T2-weighted brain lesion load providing a...

    P. D. Molyneux, D. H. Miller, M. Filippi, T. Yousry, L. Kappos in Journal of Neurology (2000)

  7. No Access

    Article

    Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images

    Previous studies have addressed the question of the precision in assessing multiple sclerosis (MS) activity by counting enhancing lesions on gadolinium enhanced brain magnetic resonance imaging (MRI). However...

    M. Rovaris, F. Barkhof, S. Bastianello, C. Gasperini, N. Tubridy in Journal of Neurology (1999)

  8. No Access

    Article

    Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging

    This study assessed whether dysfunction of the blood-brain barrier is an obligatory early event in lesion formation in multiple sclerosis. Dual-echo and T1-weighted magnetic resonance imaging after the inject...

    C. Tortorella, M. Codella, M. A. Rocca, C. Gasperini, R. Capra in Journal of Neurology (1999)

  9. No Access

    Article

    Fatigue and magnetic resonance imaging activity in multiple sclerosis

    Fatigue is a frequent and often severe symptom in multiple sclerosis. Pathogenic mechanisms proposed for fatigue include the release of proinflammatory cytokines, which is thought to have an important effect ...

    C. Mainero, J. Faroni, C. Gasperini, M. Filippi, E. Giugni in Journal of Neurology (1999)

  10. No Access

    Article

    Four-year follow-up of a case of acute multiple sclerosis of the Marburg type

    We describe the clinical course, treatment and magnetic resonance findings during a four-year follow-up of a patient with acute multiple sclerosis of the Marburg type, treated with steroid and mannitol therapy...

    Dott F. Giubilei, A. Sarrantonio, P. Tisei in The Italian Journal of Neurological Scienc… (1997)

  11. No Access

    Article

    Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

    We designed a randomized, placebo-controlled, multicentre trial involving 51 relapsing-remitting multiple sclerosis patients to determine the clinical efficacy of mitoxantrone treatment over 2 years. Patients...

    E. Millefiorini, C. Gasperini, C. Pozzilli, F. D’Andrea in Journal of Neurology (1997)

  12. No Access

    Article

    High-dose contrast-enhanced MRI in multiple sclerosis

    Contrast-enhanced MRI is effective for assessing disease activity in multiple sclerosis (MS) and may provide an outcome measure for testing the efficacy of treatment in clinical trials. To compare the sensitiv...

    T. Koudriavtseva, C. Pozzilli, C. Gasperini, C. Argentino, C. Di Biasi in Neuroradiology (1996)

  13. No Access

    Chapter and Conference Paper

    MRI and neuropsychological correlates in presumed vascular dementia

    We studied 34 patients with presumed vascular dementia (20 men and 14 women, average: 69.86) on a 0.2T MR system. T2-weighted on axial images and T1-weighted midsaggital images were obtained. The volumes of th...

    S. Bastianello, F. Giubilei, A. Paolillo in Proceedings of the XV Symposium Neuroradio… (1995)

  14. No Access

    Chapter and Conference Paper

    Early Treatment of Stroke in Man

    According to data from the Rochester study, both stroke incidence and mortality had declined more than 50%, and long-term survival had improved over 70% from 1945–1949 to 1970–1974 (Whisnant 1983). However, no...

    C. Fieschi, C. Argentino, C. Pozzilli, M. Rasura in Neuropsychological Rehabilitation (1992)

  15. No Access

    Article

    Irreversible total blindness in multiple sclerosis

    C. Gasperini, C. Pozzilli, S. Bernardi in The Italian Journal of Neurological Sciences (1991)